New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
PsyPost on MSN2d
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linkedA Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...
Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...
For significant weight loss, Zepbound may be the better option. If you have Type 2 diabetes and are looking for a dual ...
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
ScienceDaily: Some Diabetes Drugs Tied To Lower Risk Of Dementia, Parkinson's Disease A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, ...
A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study ...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback